Mesenchymal stem cells cancel azoxymethane-induced tumor initiation

Area of Science:

• Oncology
• Stem Cell Biology
• Gastroenterology

Background:

• The role of mesenchymal stem cells (MSCs) in cancer development is debated.
• Understanding MSCs' effects on tumorigenesis is crucial for cancer therapy development.

Purpose of the Study:

• To investigate the intrinsic antineoplastic or proneoplastic properties of exogenous MSCs in azoxymethane (AOM)-induced colon carcinogenesis.
• To elucidate the mechanisms underlying MSCs' effects on tumor initiation, promotion, and DNA damage response.

Main Methods:

• Utilized three in vivo models: AOM/dextran sulfate sodium colitis-associated carcinoma, aberrant crypt foci, and acute apoptotic response to genotoxic carcinogen (AARGC).
• Conducted in vitro coculture experiments with rat intestinal cells (IEC-6).
• Assessed O(6)-methylguanine (O(6) MeG) adduct removal, cell-cycle progression, apoptosis, and transforming growth factor-beta (TGF-β) signaling.

Main Results:

• MSCs partially inhibited AOM-induced tumor initiation but not tumor promotion.
• MSCs reduced the AARGC by activating O(6) MeG-DNA methyltransferase, removing O(6) MeG adducts.
• MSCs induced G1 cell-cycle arrest and apoptosis in intestinal cells, dependent on TGF-β signaling.

Conclusions:

• MSCs exhibit anti-carcinogenetic properties by inhibiting tumor initiation and inducing cell-cycle arrest.
• TGF-β signaling is essential for MSCs' anti-carcinogenic effects.
• Further understanding of MSC functions is necessary for clinical applications in cancer-prone patients, especially those with inflammatory bowel disease.